Metabolic Research Institute
 High Quality Assessment & Medical Care . . . Teaching . . . Research

CONTACT US

  HOME     WHO WE ARE    MISSION STATEMENT    FOCUS & EXPERTISE    AFFILIATIONS


1515 N. Flagler Drive
Suite 440
West Palm Beach, FL 33401
USA

Tel:     (561) 802-3060
 Fax:    (561) 802-3260
 


 

Our Brochure

Our Newsletter

Adobe Acrobat Reader is required to view these files. To download your free copy of this software click here:
 
Get Acrobat Reader


DIRECTORS

The Metabolic Research Institute:  Patient Care  -  Teaching  - Research.  For over 20 years, Drs. Barry Horowitz and Bill Kaye have been involved in various metabolic research studies.  Focusing on those investigations that explore the link between diabetes and heart disease, they have also investigated the effectiveness of the various types of diabetic medications currently available in today's marketplace.

  • William A. Kaye, M.D., F.A.C.P.
         Dr. Kaye received his B.A. and M.D. from Brown University.  He completed his internship and residency at the Brown University affiliated hospitals and his fellowship in Nephrology at Cornell University Medical Center New York Hospital.

    Following his fellowship program, Dr. Kaye spent the next several years on the faculty of Harvard Medical School and the Joslin Diabetes Center as a board-certified Endocrinologist and Nephrologist.

     

  • Barry S. Horowitz, M.D., F.A.C.P., F.A.C.E.
         Dr. Horowitz received his B.A. from Cornell University and his M.D. from Albert Einstein College of Medicine.  He completed his internship and residency in Internal Medicine as well as his fellowship in Endocrinology at Columbia Presbyterian Medical Center, New York.

Dr. Kaye and Dr. Horowitz have published extensively in major medical journals in the fields of hyperlipidemia, nephrology, diabetes and hypertension.

Both physicians continue to lecture, locally and nationally, on a wide variety of topics in the field  of endocrinology and metabolism.

These physicians' love of discovery, combined with their quest to remain on the cutting edge of advances in medicine, fostered the development of the Metabolic Research Unit. 

Their strong backgrounds in medical research also attracted the attention of major pharmaceutical companies who were seeking to collaborate with reputable firms during clinical phase trials of newly discovered drug protocols developed for use in the treatment of diabetes and other related medical disorders, including hypertension and heart disease.


"We offer our patients both the conventional approach to the treatment of their medical condition, as well as the opportunity to participate in the clinical testing of new products, often two to four years before these drugs are available to the general population," explains Dr. Kaye. "Typically a select group of our current patients will participate in one of our ongoing clinical trials in order to find a new treatment for their existing illness that may be better than what is currently available, or to discover a new way of using an old treatment more effectively."